Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar
All clinical trials, All demyelinating disease (CNS), Autoimmune diseases, Devic's syndrome, Neuromyelitis optica spectrum disorder, Patient safety,
Related Posts
Wang L, Shi Y, Qureshi TA, Xie Y, Gaddam S, Azab L, Wu C, He Y, Deng Z, Javed S, Diwan G, Vendrami CL, Rodriguez[...]
Jin K, Gong A-Y, Wang S, Martins GA, Strauss-Soukup JK, O'Connor RM, Chen X-M. Targeting the interaction between long noncoding RNA XR_001779380 and Prdm1 to[...]
Dua A, Narasimhalu T, Hamidi S, Dewan R, Nulsen B. Tumoral Melanosis of the Colon: A Rare Manifestation of Regressed Melanoma. ACG Case Rep J.[...]